484 related articles for article (PubMed ID: 26610420)
1. The Changing Epidemiology of Meningococcal Disease.
Cohn A; MacNeil J
Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of meningococcal disease and the impact of vaccines.
Khatami A; Pollard AJ
Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
[TBL] [Abstract][Full Text] [Related]
3. An Update on Meningococcal Vaccination.
Garland JM
R I Med J (2013); 2020 Aug; 103(6):41-43. PubMed ID: 32752565
[TBL] [Abstract][Full Text] [Related]
4. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
5. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
[TBL] [Abstract][Full Text] [Related]
6. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
Soriano-Gabarró M; Wolter J; Hogea C; Vyse A
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785
[TBL] [Abstract][Full Text] [Related]
7. Challenges for development of meningococcal vaccines in infants and children.
Deasy A; Read RC
Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
[TBL] [Abstract][Full Text] [Related]
8. Neisseria meningitidis B vaccines.
Panatto D; Amicizia D; Lai PL; Gasparini R
Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
[TBL] [Abstract][Full Text] [Related]
9. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
Pace D
Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF
BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998
[TBL] [Abstract][Full Text] [Related]
12. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
[TBL] [Abstract][Full Text] [Related]
14. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.
Tartof S; Cohn A; Tarbangdo F; Djingarey MH; Messonnier N; Clark TA; Kambou JL; Novak R; Diomandé FV; Medah I; Jackson ML
PLoS One; 2013; 8(5):e63605. PubMed ID: 23671685
[TBL] [Abstract][Full Text] [Related]
15. Meningococcal conjugate vaccines.
Zimmer SM; Stephens DS
Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
[TBL] [Abstract][Full Text] [Related]
16. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
[TBL] [Abstract][Full Text] [Related]
17. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
Yezli S
Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
[TBL] [Abstract][Full Text] [Related]
18. [Neisseria meningitidis: new vaccines and preventive strategies].
Morciano L; Zaratti L; Franco E
Ig Sanita Pubbl; 2012; 68(1):97-104. PubMed ID: 22507995
[TBL] [Abstract][Full Text] [Related]
19. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
Poland GA
Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
[TBL] [Abstract][Full Text] [Related]
20. Impact of vaccination on meningococcal epidemiology.
Stefanelli P; Rezza G
Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
